This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

How to Get Stock Exposure to Gluten-Free Movement

NEW YORK (TheStreet) -- The gluten-free diet movement is all over the news and, more importantly, in more and more restaurants. Reports estimate the size of the gluten-free market to be anywhere from $500 million to $10 billion. That's a rather large expanse, but just view it as growth potential.

A gluten-free diet excludes foods containing a protein composite found in wheat, barley, rye and triticale. It is also the only medically accepted treatment for celiac disease, an illness attacking the small intestine due to the presence of gluten. 

There are a few publicly traded companies that sell products aimed largely at consumers honing to a gluten-free diet. They are stocks with small market capitalizations, meaning that share liquidity is low, volatility can be high, factor that can make such stocks difficult or risky to trade. 

RiceBran Technologies (RIBT - Get Report) is a human-food ingredient and animal nutrition based in Scottsdale, Ariz. focused on the procurement, bio-refining and marketing of products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows it to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products.

RiceBran sells products which are used by food manufacturers to create gluten free, hypoallergenic, minimally processed and non-GMO, nutrition-rich products used in pasta, baked goods, pizza dough, cereals, ground meats, healthy beverages and numerous other applications.

RiceBran generated $35 million in revenue in 2013, though it wasn't profitable on the basis of earnings before interest, taxes, depreciation and amortization, or EBITDA, a widely-followed metric. The 2014 forecast is for 69% revenue growth and $2 EBITDA per share. RiceBran has approximately 3 million shares outstanding and a market capitalization of approximately $19 million. 

A second stock focused on the gluten-free market is Senomyx  (SNMX) discovers, develops and commercializes flavor ingredients for packaged foods and beverage. The San Diego-based company has a market capitalization of $319 million and has forecasted revenue to fall in the range of $32 million to $35 million for 2014, generated a loss of about $10 million to $12 million.

Amira Nature Foods (ANFI) , which is based in Dubai, United Arab Emirates, engages in processing, distributing, and marketing packaged specialty rice and other food products. Amira has a market capitalization of $459 million and trades at trailing 12-month EV/EBITDA of 9.1.

If RiceBran were to trade at 5 times its 2014 EBITDA, it would be a $10 stock, and at 10 times its 2014 EBITDA, the stock would trade at $20. RiceBran is as a nice way to get exposure to the gluten-free diet movement, which is why I'm long on the stock.

At the time of publication, the author owned ANFI.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
RIBT $1.29 -4.44%
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs